Yongin-si, South Korea

Jeonghyeok Yoon


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jeonghyeok Yoon

Introduction

Jeonghyeok Yoon is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents. His work focuses on creating compounds that can effectively combat viral infections, showcasing his dedication to improving public health.

Latest Patents

Yoon holds a patent for 5,6-dimethylthieno[2,3-di]pyrimidine derivatives, which are recognized for their potential as antiviral agents. This patent details a preparation method for these derivatives and their application in pharmaceutical compositions aimed at preventing and treating hepatitis C virus (HCV). The compounds demonstrated an excellent inhibitory effect on the proliferation of HCV while maintaining low toxicity, making them promising candidates for therapeutic use.

Career Highlights

Throughout his career, Jeonghyeok Yoon has been associated with Equispharm Co., Ltd., where he has contributed to various research initiatives. His innovative approach and commitment to developing effective antiviral treatments have positioned him as a key figure in his field. His work not only reflects his expertise but also his passion for advancing medical science.

Collaborations

Yoon has collaborated with notable colleagues, including Cheol Han and Nam-Doo Kim. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Jeonghyeok Yoon's contributions to antiviral research and his innovative patent for 5,6-dimethylthieno[2,3-di]pyrimidine derivatives highlight his significant role in the pharmaceutical industry. His work continues to pave the way for advancements in the treatment of viral infections, particularly hepatitis C.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…